EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reciprocal Regulation of GLI1 and GLI3 Fine Tunes the Pathogenic Behavior of Synovial Fibroblasts in Rheumatoid Arthritis

Motohiko Sato iD, Tetsuya Saito iD, Yoji Komiya, Seiji Noda iD, Yasuhiro Tagawa, Akio Yamamoto iD, Hideyuki Iwai, Kentaro Endo iD, Hideyuki Koga, Yasuhiro Takahara, Kazutaka Sugimoto, Ichiro Sekiya iD und 3 weitere

International Journal of Rheumatic Diseases · 2026

DOI: 10.1111/1756-185x.70690 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, 2026. Verfasst von Motohiko Sato und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo (IST), Tokyo, Japan. Hauptthemen laut MEDLINE: Zinc Finger Protein GLI1, Fibroblasts, Arthritis, Rheumatoid, Zinc Finger Protein Gli3. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science London.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We investigated the role of GLI3, a transcription factor highly expressed in the pathogenic THY1 + CD34 − sublining subset of rheumatoid arthritis synovial fibroblasts (RASFs), in regulating their pathogenic behavior.

Methods

GLI3 protein levels were quantified in freshly isolated RASF subsets by Western blotting. Bulk RASFs were subjected to siRNA‐mediated knockdown (KD) of GLI3 or GLI1, followed by RNA sequencing. The effects of GANT61 on RASF proliferation, cell‐cycle progression, migration, viability, and apoptosis were assessed using EdU/PI analysis, scratch assays, CCK‐8 assays, and Annexin V/PI flow cytometry.

Results

GLI3 expression was enriched in THY1 + CD34 − RASFs at both mRNA and protein levels. GLI3 KD increased GLI1 expression and upregulated genes involved in inflammation, matrix remodeling, and cell cycle regulation, including IL6, IL11, IL24, IL33, MMP3, PLAU, CCNA2, and E2F1. Pathway enrichment analysis revealed activation of ECM–receptor interaction, PI3K–Akt, and TNF signaling. Co‐silencing GLI1 with GLI3 blunted the induction of IL11, IL24, IL33, CCNA2, E2F1, and PLAU observed with GLI3 KD alone, indicating that GLI1 mediates a subset of the transcriptional effects induced by GLI3 loss. GANT61 suppressed CCNA2 and E2F1 expression, inhibited RASF proliferation and migration, and did not markedly increase apoptosis.

Conclusion

GLI3 functions as a negative regulator of GLI1 and its downstream targets that drive the pathogenic behavior of RASFs. Targeting the GLI1–GLI3 axis may represent a promising therapeutic strategy to modulate fibroblast‐driven inflammation and joint destruction in RA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zinc Finger Protein GLI1FibroblastsArthritis, RheumatoidZinc Finger Protein Gli3Synovial MembraneNerve Tissue ProteinsHumansSignal TransductionApoptosisCell ProliferationPyrimidinesCell MovementCells, CulturedPyridinesGene Expression Regulation

Stichwörter der Autor:innen

GLI1GLI3fibroblasthedgehog signaling pathwayrheumatoid arthritis

Substanzen

Zinc Finger Protein GLI1GLI1 protein, humanGANT 61Zinc Finger Protein Gli3PyrimidinesGLI3 protein, humanPyridinesNerve Tissue Proteins

Autor:innen und Institutionen

  • Department of Rheumatology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo (IST), Tokyo, Japan.
  • Center for Stem Cell and Regenerative Medicine, Institute of Science Tokyo (IST), Tokyo, Japan.
  • Department of Joint Surgery and Sports Medicine, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo (IST), Tokyo, Japan.
  • Department of Orthopedic Surgery, Nippon Kokan Fukuyama Hospital, Hiroshima, Japan.
  • Department of Orthopedics, Sonodakai Joint Replacement Center Hospital, Tokyo, Japan.
  • Department of Artificial Intelligence Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.

ORCID-Profile: Motohiko Sato, Tetsuya Saito, Seiji Noda, Akio Yamamoto, Kentaro Endo, Ichiro Sekiya

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science London

Zitieren

APA

Sato, M., Saito, T., Komiya, Y., Noda, S., Tagawa, Y., Yamamoto, A., Iwai, H., Endo, K., Koga, H., Takahara, Y., Sugimoto, K., Sekiya, I., Kawakami, E., Hosoya, T., & Yasuda, S. (2026). Reciprocal Regulation of GLI1 and GLI3 Fine Tunes the Pathogenic Behavior of Synovial Fibroblasts in Rheumatoid Arthritis. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70690

Vancouver

Sato M, Saito T, Komiya Y, Noda S, Tagawa Y, Yamamoto A, et al. Reciprocal Regulation of GLI1 and GLI3 Fine Tunes the Pathogenic Behavior of Synovial Fibroblasts in Rheumatoid Arthritis. International Journal of Rheumatic Diseases. 2026. doi:10.1111/1756-185x.70690

BibTeX
@article{Sato2026,
  author = {Sato, Motohiko and Saito, Tetsuya and Komiya, Yoji and Noda, Seiji and Tagawa, Yasuhiro and Yamamoto, Akio and Iwai, Hideyuki and Endo, Kentaro and Koga, Hideyuki and Takahara, Yasuhiro and Sugimoto, Kazutaka and Sekiya, Ichiro and Kawakami, Eiryo and Hosoya, Tadashi and Yasuda, Shinsuke},
  title = {Reciprocal Regulation of GLI1 and GLI3 Fine Tunes the Pathogenic Behavior of Synovial Fibroblasts in Rheumatoid Arthritis},
  journal = {International Journal of Rheumatic Diseases},
  year = {2026},
  doi = {10.1111/1756-185x.70690}
}
Kostenlos starten →